Debt-to-equity in % of GUIDED THERAPEUTICS INC from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GUIDED THERAPEUTICS INC quarterly Debt-to-equity history and change rate from Q3 2019 to Q3 2025.
  • GUIDED THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -1 %, a 9.53% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1 +0 +9.5% 30 Sep 2025
Q2 2025 -1 +0 +12% 30 Jun 2025
Q1 2025 -1 +0 +16.8% 31 Mar 2025
Q4 2024 -1 +0 +21.5% 31 Dec 2024
Q3 2024 -1 +0 +27.4% 30 Sep 2024
Q2 2024 -1 +1 +32.7% 30 Jun 2024
Q1 2024 -1 +0 +17.7% 31 Mar 2024
Q4 2023 -1 +0 +1.6% 31 Dec 2023
Q3 2023 -1 -0 -20.9% 30 Sep 2023
Q2 2023 -2 -1 -72.1% 30 Jun 2023
Q1 2023 -1 -1 -65.1% 31 Mar 2023
Q4 2022 -1 -1 -52.4% 31 Dec 2022
Q3 2022 -1 -0 -42.2% 30 Sep 2022
Q2 2022 -1 -0 -8.5% 30 Jun 2022
Q1 2022 -1 +0 +1.5% 31 Mar 2022
Q4 2021 -1 -0 -2% 31 Dec 2021
Q3 2021 -1 0 +0.29% 30 Sep 2021
Q2 2021 -1 -0 -5.9% 30 Jun 2021
Q1 2021 -1 -0 -8.4% 31 Mar 2021
Q4 2020 -1 -0 -4.3% 31 Dec 2020
Q3 2020 -1 -0 -4.6% 30 Sep 2020
Q2 2020 -1 30 Jun 2020
Q1 2020 -1 31 Mar 2020
Q4 2019 -1 31 Dec 2019
Q3 2019 -1 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.